IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2006;47:158-168.)
© 2006 by The Association for Research in Vision and Ophthalmology, Inc.
doi:10.1167/iovs.05-1003

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suzuki, T.
Right arrow Articles by Sullivan, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suzuki, T.
Right arrow Articles by Sullivan, D. A.

Estrogen’s and Progesterone’s Impact on Gene Expression in the Mouse Lacrimal Gland

Tomo Suzuki,1,2 Frank Schirra,1,2 Stephen M. Richards,1,2 Nathaniel S. Treister,1,3 Michael J. Lombardi,4 Patricia Rowley,4 Roderick V. Jensen,4 and David A. Sullivan1,2

1From the Schepens Eye Research Institute and 2Department of Ophthalmology, Harvard Medical School; 3Department of Oral Medicine, Infection, and Immunity, Harvard School of Dental Medicine; and 4Department of Physics, University of Massachusetts Boston, Boston, Massachusetts.

PURPOSE. The hypothesis tested in the study was that the effect of estrogen and progesterone on the lacrimal gland is mediated through specific receptors and that hormonal effects involve the regulation of gene expression and protein synthesis.

METHODS. Lacrimal glands were collected from young adult, ovariectomized mice, that were treated with 17ß-estradiol, progesterone, 17ß-estradiol plus progesterone or vehicle for 2 weeks. Glands were pooled according to treatment, processed for the isolation of RNA, and evaluated for differentially expressed mRNAs by using gene microarrays. Bioarray data were analyzed with sophisticated bioinformatics and statistical programs. The expression of selected genes was verified by using gene chips and quantitative real-time PCR methods.

RESULTS. The results demonstrate that 17ß-estradiol, progesterone, or both hormones together significantly influences the expression of hundreds of genes in the mouse lacrimal gland. Sex steroid treatment led to numerous alterations in gene activities related to transcriptional control, cell growth and/or maintenance, cell communication, signal transduction, enzyme catalysis, immune expression, and the binding and metabolism of nucleic acids and proteins. A number of the 17ß-estradiol, progesterone or 17ß-estradiol plus progesterone effects on gene expression were similar, but most were unique to each treatment. Of particular interest was the finding that these hormones seem to contribute little to the known sex-related differences in gene expression of the lacrimal gland.

CONCLUSIONS. These results support the hypothesis that estrogen’s and progesterone’s action on the lacrimal gland involves the regulation of numerous genes. However, these hormone effects do not appear to represent a major factor underlying the sexual dimorphism of gene expression in lacrimal tissue.





This article has been cited by other articles:


Home page
J. Nutr.Home page
I. Ueki and M. H. Stipanuk
Enzymes of the Taurine Biosynthetic Pathway Are Expressed in Rat Mammary Gland
J. Nutr., August 1, 2007; 137(8): 1887 - 1894.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Association for Research in Vision and Ophthalmology